LoginSignup
Sartorius Pref Shs logo

Sartorius Pref Shs

Stock
Stock
ISIN: DE0007165631
Ticker: SRT3
DE0007165631
SRT3

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Sartorius Pref Shs has so far distributed $0.856 in 2026. The next dividend will be paid on 31.03.2027

$0.539

CHART BY

Frequently asked questions

The market capitalization of Sartorius Pref Shs is $18.69B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Sartorius Pref Shs is 82.13. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Sartorius Pref Shs's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.295. EPS indicates the company's profitability on a per-share basis.
Currently, 23 analysts cover Sartorius Pref Shs's stock, with a consensus target price of $325.34. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Sartorius Pref Shs reported a revenue of $4.16B.
Sartorius Pref Shs's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.23B. EBITDA measures the company's overall financial performance.
Sartorius Pref Shs has a free cash flow of $317.13M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Sartorius Pref Shs employs approximately 14,042 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Sartorius Pref Shs is 23.46M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$18.69B
EPS (TTM) 
$3.295
Free Float 
23.46M
P/E ratio (TTM) 
82.13
Revenue (TTM) 
$4.16B
EBITDA (TTM) 
$1.23B
Free Cashflow (TTM) 
$317.13M

Pricing

1D span
$267.20$271.79
52W span
$222.94$314.52

Analyst Ratings

The price target is $325.34 and the stock is covered by 23 analysts.

Buy

17

Hold

5

Sell

1

Information

Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through the Bioprocess Solutions (BPS) and Lab Products and Service (LPS) segment. The BPS segment focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The LPS segment serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Employees
14,042
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE0007165631
Primary Ticker
SRT3

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin